account_num,net_change,tag,tag_depth,cik
1572,115000.0,FinanceLeaseRightOfUseAsset,3,719135_APYX MEDICAL CORP
2431,94000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,719135_APYX MEDICAL CORP
3853,-211000.0,MinorityInterest,1,719135_APYX MEDICAL CORP
487,99000.0,OtherReceivablesNetCurrent,3,719135_APYX MEDICAL CORP
2603,-44510000.0,NoninterestIncome,1,719135_APYX MEDICAL CORP
110,-44510000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,719135_APYX MEDICAL CORP
2004,-651000.0,OtherNonoperatingIncomeExpense,1,719135_APYX MEDICAL CORP
581,4544000.0,OperatingCostsAndExpenses,2,719135_APYX MEDICAL CORP
491,4544000.0,ResearchAndDevelopmentExpense,2,719135_APYX MEDICAL CORP
144,15379000.0,CostOfRevenue,1,719135_APYX MEDICAL CORP
171,15379000.0,CostOfGoodsAndServicesSold,2,719135_APYX MEDICAL CORP
3494,-181000.0,OtherLiabilitiesNoncurrent,2,719135_APYX MEDICAL CORP
2552,-8928000.0,AccruedLiabilitiesCurrent,2,719135_APYX MEDICAL CORP
644,7545000.0,NontradeReceivablesCurrent,2,719135_APYX MEDICAL CORP
599,7545000.0,IncomeTaxesReceivable,2,719135_APYX MEDICAL CORP
2903,-23184000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,719135_APYX MEDICAL CORP
2590,-23184000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,719135_APYX MEDICAL CORP
1912,-23184000.0,NetIncomeLoss,1,719135_APYX MEDICAL CORP
1077,-23278000.0,ProfitLoss,2,719135_APYX MEDICAL CORP
990,-75000.0,GainLossOnDispositionOfAssets,4,719135_APYX MEDICAL CORP
1820,-23278000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,719135_APYX MEDICAL CORP
421,-157000.0,NetInvestmentIncome,1,719135_APYX MEDICAL CORP
3279,-1408000.0,DeferredRevenueNoncurrent,2,719135_APYX MEDICAL CORP
1749,18621000.0,SalariesWagesAndOfficersCompensation,4,719135_APYX MEDICAL CORP
1056,18621000.0,SalariesAndWages,5,719135_APYX MEDICAL CORP
1515,-509000.0,OtherOperatingIncomeExpenseNet,2,719135_APYX MEDICAL CORP
1895,9044000.0,ProfessionalFees,1,719135_APYX MEDICAL CORP
693,-157000.0,InterestIncomeOperating,2,719135_APYX MEDICAL CORP
3339,-1408000.0,ContractWithCustomerLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
2399,367000.0,IncomeTaxExpenseBenefit,1,719135_APYX MEDICAL CORP
2257,-22911000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,719135_APYX MEDICAL CORP
2149,-24228000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,719135_APYX MEDICAL CORP
3154,-11850000.0,LiabilitiesCurrent,2,719135_APYX MEDICAL CORP
2638,-37000.0,DebtCurrent,2,719135_APYX MEDICAL CORP
2737,-37000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,719135_APYX MEDICAL CORP
2809,-37000.0,FinanceLeaseLiabilityCurrent,3,719135_APYX MEDICAL CORP
2347,-11597000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,719135_APYX MEDICAL CORP
2398,-2669000.0,AccountsPayableCurrent,2,719135_APYX MEDICAL CORP
2089,51775000.0,Assets,1,719135_APYX MEDICAL CORP
2091,8803000.0,AssetsNoncurrent,2,719135_APYX MEDICAL CORP
2041,1217000.0,OtherAssetsNoncurrent,2,719135_APYX MEDICAL CORP
1368,6761000.0,PropertyPlantAndEquipmentNet,4,719135_APYX MEDICAL CORP
1634,710000.0,OperatingLeaseRightOfUseAsset,2,719135_APYX MEDICAL CORP
868,42972000.0,AssetsCurrent,2,719135_APYX MEDICAL CORP
260,11797000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,719135_APYX MEDICAL CORP
455,11797000.0,InventoryNet,2,719135_APYX MEDICAL CORP
320,18246000.0,ReceivablesNetCurrent,3,719135_APYX MEDICAL CORP
207,10602000.0,AccountsNotesAndLoansReceivableNetCurrent,4,719135_APYX MEDICAL CORP
229,10602000.0,AccountsReceivableNetCurrent,3,719135_APYX MEDICAL CORP
577,10192000.0,CashCashEquivalentsAndShortTermInvestments,4,719135_APYX MEDICAL CORP
645,10192000.0,CashAndCashEquivalentsAtCarryingValue,3,719135_APYX MEDICAL CORP
3378,-73000.0,FinanceLeaseLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
3303,-73000.0,LongTermDebtAndCapitalLeaseObligations,2,719135_APYX MEDICAL CORP
3379,-470000.0,OperatingLeaseLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
3796,-2059000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,719135_APYX MEDICAL CORP
1854,15000.0,InterestAndDebtExpense,2,719135_APYX MEDICAL CORP
1709,15000.0,InterestExpense,1,719135_APYX MEDICAL CORP
2130,-651000.0,NonoperatingIncomeExpense,1,719135_APYX MEDICAL CORP
1264,-23562000.0,OperatingIncomeLoss,1,719135_APYX MEDICAL CORP
1112,52693000.0,OperatingExpenses,1,719135_APYX MEDICAL CORP
1002,-75000.0,GainLossOnDispositionOfAssets1,1,719135_APYX MEDICAL CORP
961,-75000.0,GainLossOnSaleOfPropertyPlantEquipment,1,719135_APYX MEDICAL CORP
692,315000.0,ProvisionForDoubtfulAccounts,2,719135_APYX MEDICAL CORP
601,20484000.0,SellingGeneralAndAdministrativeExpense,3,719135_APYX MEDICAL CORP
597,27665000.0,GeneralAndAdministrativeExpense,2,719135_APYX MEDICAL CORP
173,-157000.0,Revenues,1,719135_APYX MEDICAL CORP
3917,-51775000.0,LiabilitiesAndStockholdersEquity,2,719135_APYX MEDICAL CORP
3260,-37793000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,719135_APYX MEDICAL CORP
3316,-37582000.0,StockholdersEquity,1,719135_APYX MEDICAL CORP
3834,-35735000.0,RetainedEarningsAccumulatedDeficit,1,719135_APYX MEDICAL CORP
3750,-73282000.0,AdditionalPaidInCapital,1,719135_APYX MEDICAL CORP
3661,-35000.0,CommonStockValue,3,719135_APYX MEDICAL CORP
3465,-13982000.0,Liabilities,1,719135_APYX MEDICAL CORP
3645,-2132000.0,LiabilitiesNoncurrent,2,719135_APYX MEDICAL CORP
232,-29131000.0,GrossProfit,1,719135_APYX MEDICAL CORP
